eefit Returns to the International Academic Stage — Patented Far Infrared Technology Praised by Nobel Laureate and Renowned Scientists
HONG KONG SAR - Media OutReach Newswire - 12 August 2025 - With a rapidly increasing aging population,Modern medicine has standardised our current diagnosis and treatment system, especially in the intervention of acute symptoms and pathological control. However, in the face of health needs such as long-term management of chronic diseases and conditioning of sub-health problems, which require a "holistic view" and "continuous repair", its limitations in areas such as healthcare, functional restoration, and improvement of quality of life are gradually becoming apparent.was held in June 2025.revealing to the world the innovative application of their patented far infrared technology in healthcare, with results verified by internationally renowned academics and authorities. The benefit provides systematic health management solutions for the middle-aged and elderly population through non-invasive and non-drug methods, creating a new chapter in health technology.Organized by the Macau University of Science and Technology (M.U.S.T.), this forum brought together experts in various disciplines from around the world, including neuroscientists and biophysicists. In attendance was, who attended the event as the keynote speaker. It's worth noting that eefit has been collaborating closely with "Dr. Neher's Biophysics Laboratory for Innovative Drug Discovery" since 2021, promoting transformative scientific research in far infrared technology.introduced the significant effects of eefit's patented far infrared technology in improving intestinal microecology, regulating cell immunity, and alleviating symptoms of rheumatoid arthritis. His team's latest research has confirmed that this technology not only can enhance cerebral blood flow and reduce brain damage in patients with ischemic stroke but can also provide an innovative solution for rehabilitation treatment.The middle-aged and elderly population is plagued by health issues, such as chronic pain, sleep disorders, immune system disorders, and Alzheimer's disease. eefit provides comprehensive solutions to address these issues through developing innovative healthcare products. At the forum, experts gathered at the booth set up by eefit to experience firsthand how technology redefines the health management of the elderly.eefit's patented technology reduces the risk of Alzheimer's disease by reducing Aβ deposits and abnormal tau proteins. The latest research paper presented on-site showed that eefit far infrared energy can penetrate the blood-brain barrier, intervene in pathological protein aggregation, and build a strong line of defense for brain health.For patients suffering from sequelae of stroke, eefit Luminous Energy Helmet and Meridian Pro Illuminator can promote microcirculation in the head and improve cerebral blood flow. The research conducted by the research team of Prof. Vincent Wong has confirmed that this technology can reduce stroke sequelae symptoms and dizziness. An expert user at the forum excitedly shared his feedback, "I am a loyal fan of eefit products. I wear the Luminous Energy Helmet for 20 minutes daily. After one month, I find my memory improved, and I don't get dizzy as often."In the field of pain management, products like EEFit Lite can accurately irradiate pain points and inhibit the release of inflammatory factors. Experts verified that "10 minutes of irradiation can reduce knee pain on a pain scale from 6 to 3, with effects lasting for more than 2 hours".eefit far infrared technology can relieve insomnia by regulating nervous system functions. eefit data shows that after daily use for 2 weeks, over 80% of users experienced a 50% reduction in the time they took to fall asleep, as well as an increased duration of deep sleep.eefit far infrared energy achieves two-way regulation of gut microbiota in an innovative manner by inhibiting the excessive proliferation of pathogens while promoting the growth of beneficial bacteria and regulating the imbalance of intestinal microecology. Experimental data shows that after two weeks of intervention, the alpha diversity of gut microbiota (Chao1 index) increased by 30%, and abdominal bloating decreased by 45%.eefit first introduced far infrared technology into health management through independent technology R&D and commercialization execution, which then attracted collaboration with reputable scientific research institutions. ThisAt the forum banquet, eefit's Founder and Chairman Prof. Nick Wang remarked, "We are honoured, looking back on our eight-year partnership between eefit and the research laboratory. This period of collaboration with deep integration of industry, academia and research has not only pioneered groundbreaking research but also produced fruitful scientific and technological achievements." He emphasized that eefit has always been "user demand-oriented" at its core, by first verifying the value of technology through market research and then extending the application boundaries with the help of prominent scientific researchers to achieve a seamless connection "from lab to real life".eefit's future development focuses on three strategic directions:, they will continue to increase their investment on R&D and explore new boundaries of far infrared technology applications in more areas that impact human health; In terms of, they will strengthen partnerships with notable international scientific research institutions and accelerate the process of global adoption; In the field of, they will popularize home healthcare solutions through verified consumer-level healthcare products such as EEFit Lite, Chi Vitaliser, and Luminous Energy Helmet; and they will continue to pioneer the extension of far infrared technology in the field of health supplements, building an all-encompassing health management system of "External healthcare devices + Internal balancing nutrition".As a leading energy healthcare technology company in Hong Kong, eefit's all-encompassing health management system has been universally recognized by respected international scientists.Hashtag: #eefit
The issuer is solely responsible for the content of this announcement.
About 'The 9th Young Scholars Conference on Ion Channels and Receptors & Forum on Biophysics and Innovative Drug Discovery'
This forum was jointly organized by the Branch of Ion Channels & Receptors, Chinese Neuroscience Society, and Macau University of Science and Technology (M.U.S.T.). It is an important academic event in China focusing on the field of ion channels and receptors. This forum has been held for eight consecutive years and is an important platform for promoting cutting-edge research, innovative drug development and cooperation, and international academic exchanges.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malay Mail
3 hours ago
- Malay Mail
New blood test with 92pc accuracy: Spotting ovarian cancer early, even when symptoms seem harmless
WASHINGTON, Aug 15 — An experimental blood test detects early-stage ovarian cancer in patients with vague symptoms that would likely be misdiagnosed using currently available methods, researchers said in a new report. Ovarian cancer is the fifth leading cause of cancer-related deaths among women, largely due to delays in diagnosis until after the disease has spread in the body, at which point it's harder to treat, according to the researchers. More than 90 per cent of patients with early-stage ovarian cancer experience symptoms that can be mistaken for benign conditions, such as bloating, abdominal pain, and digestive issues. Not only have there been no reliable blood tests for these patients, but existing invasive tests often miss early-stage ovarian tumors, the researchers noted in Cancer Research Communications. Using machine learning tools, the researchers identified multiple biomarkers – from across a wide range of molecules and processes in the body – that could be combined into a single test that detects all sub-types of the disease, at all stages, they said. Trialed at a large medical center on blood samples from nearly 400 women with possible symptoms of ovarian cancer, the test was 92 per cent accurate at identifying those with any stage of ovarian cancer and 88 per cent accurate at identifying those with Stage I or Stage II disease, according to the report. Oriana Papin-Zoghbi, chief executive officer of the company developing the new test – Denver, Colorado-based AOA Dx – said the findings show its potential to aid 'in making faster, more informed decisions for women who need urgent clarity during a challenging diagnostic process.' Preventing elders' 'leaky brain' might stave off cognitive decline The blood-brain barrier gets leakier with age, contributing to memory deficits - and new discoveries of the mechanisms behind this process might lead to new ways of preventing cognitive decline, researchers say. The blood-brain barrier - a layer of tightly-junctioned cells lining the brain's blood vessels - keeps viruses, bacteria and toxins out while allowing helpful nutrients and chemicals in. 'Basically, it's a mechanism that separates the central nervous system from everything else,' study leader Yulia Komarova of University of Illinois Chicago said in a statement. In previous research, Komarova and her colleagues found that removing a protein called N-cadherin from the cells lining blood vessels made the vessels leakier in the brain. In a new study published in Cell Reports, her team found that mice without N-cadherin could learn tasks as well as normal mice, but they quickly forgot what they learned. In further experiments, they found when N-cadherin proteins on neighboring cells interact, they stabilize a protein, called occludin, which helps form the tight junctions in the blood-brain barrier that maintains the integrity of the blood-brain barrier. Examining human brain tissue collected during epilepsy surgeries, the researchers found that samples from patients in their 40s and 50s had lower levels of N-cadherin and occludin than samples from patients in their late teens and 20s. Komarova's team is now investigating whether steps in the signaling pathway activated by N-cadherin could be therapeutic targets. 'This paper shows that actually there might be a much bigger therapeutic window for treatment of any age-related cognitive decline condition,' she said. Wildfire smoke deaths in Europe may be underestimated Previous studies may have underestimated the number of deaths related to wildfire smoke in Europe by as much as 93 per cent, according to a report in The Lancet Planetary Health. In new research, using daily mortality records from 654 contiguous regions in 32 European countries, researchers found that for every 1 microgram per cubit meter increase in wildfire smoke particles, all-cause mortality rose by 0.7 per cent, respiratory mortality by 1 per cent, and cardiovascular mortality by 0.9 per cent. Annually since 2004, short-term exposure to wildfire pollution was responsible for an average of 535 deaths from all causes, the researchers calculated – while estimates in previous studies had put that number at around 38 deaths per year, they said. 'Human-driven climate change is one of the main causes of the rising frequency and intensity of wildfires, as it creates favorable conditions for their spread and increases the number of days with very high or extremely high fire risk,' study leader Anna Alari of the Barcelona Institute for Global Health said in a statement. 'Improving estimates of (wildfire smoke related) mortality will help better track the burden of this climate change-related threat to public health.' A separate study found that as wildfire pollution levels rise, firefighters' hearts work harder, researchers wrote in Circulation Arrhythmia and Electrophysiology. After fighting the Park Fire in California, firefighters' heart rate at rest would rise by an average of 1.4 beats per minute for every 10-ug/m3 increase in particulate matter. Although the increase in resting heart rate was modest, and the rate remained within normal levels, even slight elevations have been associated with increased cardiovascular morbidity and mortality over time in large population studies. — Reuters
Malay Mail
7 hours ago
- Malay Mail
Medical insurance overhaul in progress, says BNM, with new plans set for 2026
KUALA LUMPUR, Aug 15 — Interim measures to manage rising medical costs remain effective, as ongoing initiatives will strengthen healthcare delivery and help curb medical insurance inflation, said Bank Negara Malaysia (BNM) Governor Datuk Seri Abdul Rasheed Ghaffour. He said that over the past three years, the government has implemented five key thrusts and 11 recommendations aimed at improving medical services, enhancing implementation, and addressing the rising cost of health insurance premiums. 'For example, we are revamping the medical and health insurance/takaful (MHIT) product. You may be able to see the base product. We are testing it as we go,' he told a press conference after announcing Malaysia's second-quarter 2025 gross domestic product (GDP) performance here today. The MHIT revamp involves a redesigned base product, to be completed by year-end and rolled out in selected areas next year. Abdul Rasheed said other initiatives involve strengthening the digital health system, expanding cost-effective healthcare options, leveraging primary care providers to reduce implementation costs, and transforming the primary care payment mechanism through digital tools. 'These efforts are expected to bring down payment costs and ensure a more sustainable healthcare system,' he added. Last December, BNM announced interim measures with the insurance and takaful industry to help policyholders facing premium revisions for their MHIT products, aimed at easing their immediate financial burden while preserving coverage. — Bernama
Free Malaysia Today
12 hours ago
- Free Malaysia Today
Tawau Hospital set to begin cardiology services
Health minister Dzulkefly Ahmad, visiting Tawau Hospital today, said the tender for setting up the invasive cardiac laboratory will be issued in a month or two. (Facebook pic) PETALING JAYA : Tawau Hospital is set to become a referral hospital on the east coast of Sabah for cardiology treatment soon. Health minister Dzulkefly Ahmad said this would be possible with the operation of an invasive cardiac laboratory (ICL) there, Bernama reported. He said the entire ecosystem, including the infrastructure for the ICL operations, had been identified and would be supplied immediately. 'The tender will be issued in a month or two. 'The ICL will provide services which are commonly referred to as cardiac treatment setups, angiograms, angioplasties and many more,' he said after visiting the hospital here today. He said at present heart attack and critical heart ailment patients on the east coast of Sabah have to be referred to treatment centres in Kota Kinabalu. This resulted in delayed treatment and an increased risk of complications. 'The health ministry is confident that with the operation of the ICL, we can reduce the time required for door-to-ECG to less than 10 minutes.' Dzulkefly hopes to offer the balloon procedure or angioplasty at the hospital in less than 90 minutes. 'This ICL is a very good, very fast cardiology service that is eagerly awaited by the entire Sabah population, particularly those on the east coast,' he added. Dzulkefly's three-day intensive tour of 22 health facilities in six districts in Sabah ended today.
